Eurazeo SE — M&A Activity 2020

Jul 23, 2020

EURAZEO ANNOUNCES THE SALE OF TELECLINIC, ITS VENTURE PORTFOLIO COMPANY

Paris, 23 July 2020

Eurazeo announces the sale of TeleClinic by Idinvest Partners, Germany's leading telemedicine platform, to Swiss group Zur Rose, a global pharmaceutical player and European leader in e-pharmacy. The sale has an IRR of 40%.

Founded in 2015 and part of Eurazeo's Venture portfolio since 2018, TeleClinic has been a pioneer in the development of teleconsultation and electronic prescriptions reimbursed by the German social security system.

Since the first roundtable discussion held in 2018 and fundraising of 7 million euros, TeleClinic has demonstrated its strong growth potential, bolstered by the impressive development of digital medicine. Since the Covid-19 pandemic and the constraints brought about by social distancing, its use is accelerating on a global scale.

This sale, taking place a mere 2 years after its original investment, confirms Eurazeo's Venture strategy, established more than 5 years ago in the digital health sector. Eurazeo's Venture team has thus made two investments in this sector: Firstly in Lifebit, a big data processor for medical research, and also in Kaia Health, a leader in digital therapeutics. These investments strengthen the Group's ambitions and long-term vision, in order to support the evolution of medicine and respond to the health challenges of the future.

Matthieu Baret, Managing Partner says:

With over 10 investments in digital health, our Venture Healthcare activity relies on a dedicated team, whose knowledge in the fields of both tech and healthcare has allowed us to adopt a multidisciplinary approach and achieve a rare expertise in the market.

About Eurazeo

• Eurazeo is a leading global investment company, with a diversified portfolio of €18,8 billion in assets under management, including €12,5 billion from third parties, invested in over 430 companies. With its considerable private equity, venture capital, real estate, private debt and fund of funds expertise, Eurazeo accompanies companies of all sizes, supporting their development through the commitment of its nearly 300 professionals and by offering deep sector expertise, a gateway to global markets, and a responsible and stable foothold for transformational growth. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term.
• Eurazeo has offices in Paris, New York, Sao Paulo, Seoul, Shanghai, London, Luxembourg, Frankfurt, Berlin and Madrid.
• Eurazeo is listed on Euronext Paris.
• ISIN : FR0000121121 Bloomberg : RF FP Reuters : EURA.PA

EURAZEO CONTACTS PRESS CONTACT

PIERRE BERNARDIN HEAD OF INVESTOR RELATIONS mail : pbernardin@eurazeo.com Tél : +33 (0)1 44 15 16 76

VIRGINIE CHRISTNACHT HEAD OF COMMUNICATIONS mail: vchristnacht@eurazeo.com Tel: +33 1 44 15 76 44

MAITLAND/amo DAVID STURKEN mail: dsturken@maitland.co.uk Tel: +44 (0) 7990 595 913